Levonorgestrel Stada

Levonorgestrel, the active ingredient in Levonorgestrel Stada, is a progestin presented as an oral tablet for oral use. It is employed to prevent pregnancy, both as an emergency contraceptive and as part of regular hormonal birth control regimens. It works by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining to reduce the chance of implantation.

GNH USA supplies Levonorgestrel Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice standards, ensuring product quality and traceability across global supply chains.

Levonorgestrel is a progestin used in hormonal contraceptive pathways to prevent unintended pregnancy.

Emergency contraception: provides post‑coital protection to reduce the risk of pregnancy after unprotected intercourse. Regular contraception: used as a progestin‑only oral method to inhibit ovulation and maintain contraceptive efficacy. Ovulation suppression: blocks the luteinizing hormone surge, preventing follicular rupture and egg release.

Levonorgestrel may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial pain. - Breast tenderness: temporary discomfort. - Menstrual changes: spotting or altered bleeding patterns.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis. - Blood clots: rare thromboembolic events.

Before prescribing Levonorgestrel, consider the following precautions to ensure safe use.

Pregnancy: contraindicated in known pregnancy; avoid use. Liver disease: use with caution in patients with hepatic impairment. Breast cancer: not recommended for women with active hormone‑sensitive breast cancer. Hypersensitivity: discontinue if allergic reaction occurs. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Levonorgestrel can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Rifampicin: enzyme inducer that reduces levonorgestrel levels. - St. John’s wort: herbal inducer decreasing effectiveness. - Anticonvulsants (phenytoin, carbamazepine): lower plasma concentrations.

Moderate Interactions (Monitor Closely): - Antifungals (ketoconazole, itraconazole): may increase levonorgestrel exposure. - Antiretrovirals (efavirenz, nevirapine): can alter hormone levels. - Antibiotics (rifampin, ampicillin): may modestly reduce efficacy.